marijuana stock news

Beleave Expands Recreational Cannabis Sales to Saskatchewan

Beleave Inc. (CSE: BE) (OTCQX: BLEVF) (“Beleave” or the “Company“) is pleased to announce that it has shipped its first order of recreational cannabis products for retail sale in the province of Saskatchewan.

Beleave currently distributes recreational cannabis in three other Canadian provinces; British Columbia, Manitoba, and Ontario. The Company’s current portfolio of products includes mainstream and premium product offerings of pre-rolls, oils, and dried flower under both the Beleave and Seven Oaks brand names.

“We are very happy to be officially shipping our products to Saskatchewan,” said Beleave CEO, Bill Panagiotakopoulos. “This marks another important step for Beleave in Canada – providing improved access for customers across the country. We are thrilled that the province’s residents now have the ability to purchase from Beleave’s line-up of high-quality products. We’re looking forward to expanding to even more Canadian markets in the future as we continue to invest in product innovation to drive our growth strategy forward.”

Orders and shipments were processed in June 2019, and product is expected to be ready for purchase in Saskatchewan in July 2019. The Company will update the market on sales and point-of-purchase in a future announcement.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully-licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.

Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2019. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner. Through its majority ownership of Procannmed S.A.S., Beleave is fully licensed to cultivate, produce, and extract medical cannabis in Colombia positioning it to capitalize on exports and the expanding Latin American market. The Company has partnered with Canymed GmbH to supply the German market with medical cannabis.

Investor Relations Contact:
Kevin Keagan
Interim Chief Financial Officer
Phone : 1 (647) 449 – 7352
Email :

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). The use of any of the words “plan”, “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and other similar words, or statements that certain events or conditions “may” or “will” occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$INSY to Present at RBC Capital Markets 2016 Global Healthcare Conference

Insys Therapeutics, Inc. to Present at RBC Capital Markets 2016 Global Healthcare…

$ATTBF Baby Boomers Spend Billions to Stay Young

Baby Boomers Spend Billions to Stay Young Abattis Bioceuticals Signs $25 Million…

Future Farm Technologies Inc. (FFRMF) and High Purity Natural Products to Merge

Future Farm and High Purity Natural Products to Merge Future Farm Technologies…

MustGrow Biologics Corp. (MGROF) Commences Banana ‘Panama Disease’ Testing in Colombia

MustGrow Commences Banana ‘Panama Disease’ Testing in Colombia MustGrow Biologics Corp. (CSE:…